Varian Medical Systems, Inc. (VAR) EVP Sells $225,955.46 in Stock
Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 2,018 shares of the business’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $111.97, for a total value of $225,955.46. Following the completion of the transaction, the executive vice president now directly owns 27,749 shares of the company’s stock, valued at $3,107,055.53. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Varian Medical Systems, Inc. (NYSE VAR) traded up $0.97 during mid-day trading on Wednesday, hitting $112.42. The stock had a trading volume of 1,054,644 shares, compared to its average volume of 859,464. The firm has a market capitalization of $10,300.00, a PE ratio of 29.49, a P/E/G ratio of 3.27 and a beta of 0.68. Varian Medical Systems, Inc. has a 52 week low of $76.94 and a 52 week high of $114.09.
Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.10). The firm had revenue of $739.00 million for the quarter, compared to analyst estimates of $741.69 million. Varian Medical Systems had a return on equity of 23.68% and a net margin of 8.85%. The firm’s quarterly revenue was down 1.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.03 earnings per share. equities analysts predict that Varian Medical Systems, Inc. will post 4.26 EPS for the current year.
A number of research firms have issued reports on VAR. BTIG Research cut Varian Medical Systems from a “buy” rating to a “neutral” rating in a research note on Thursday, September 7th. They noted that the move was a valuation call. Citigroup boosted their target price on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. Royal Bank of Canada set a $105.00 price objective on Varian Medical Systems and gave the stock a “hold” rating in a research report on Thursday, November 30th. Robert W. Baird reaffirmed a “hold” rating and set a $99.00 price objective on shares of Varian Medical Systems in a research report on Monday, August 28th. Finally, Zacks Investment Research cut Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company’s stock. Varian Medical Systems currently has a consensus rating of “Hold” and an average target price of $98.39.
TRADEMARK VIOLATION WARNING: This report was first published by American Banking News and is owned by of American Banking News. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.americanbankingnews.com/2017/12/13/varian-medical-systems-inc-var-evp-sells-225955-46-in-stock.html.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.